Systematic Review of Immune and Symptomatic Treatments for Stiff‐Person Syndrome
European Journal of Neurology · 2025-11 · 32 (11)
DOI: 10.1111/ene.70435 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Neurology, online erschienen am 22.11.2025. Verfasst von Timothée Lenglet und 2 weiteren Autor:innen. Beteiligte Einrichtung: Département de Neurophysiologie, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France. Hauptthemen laut MEDLINE: Stiff-Person Syndrome, Immunotherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LFB.
Abstract (Originalsprache)
Background and Purpose This systematic review evaluated the effectiveness and safety of immune and symptomatic treatments in patients with stiff‐person syndrome (SPS).
Methods
A systematic search of PubMed, Embase, and the Cochrane Library was conducted up to September 30, 2024 in accordance with the PRISMA guidelines. All studies that involve SPS patients treated with symptomatic pharmacotherapy or immunotherapy and where the outcome is reported were included in the initial screening. Case reports were excluded. Two independent reviewers carried out study selection, bias assessment with the Murad et al. tool for case series, ROBINS‐I for observational studies or RoB‐2 for randomised trials, and data extraction into a predefined template. All available efficacy and safety data were recorded. A narrative synthesis was conducted to address the heterogeneity of the studies.
Results
Thirty‐six studies were included. Most of the included studies consisted of small‐scale studies, with 21 case series, 10 cohort studies and only five randomised controlled trials. Outcome assessments varied across the reviewed studies. Most studies assessed measures with subjective self‐report and/or through clinical observations. Spasms and stiffness were assessed in around 60% of studies. Walking ability and pain were evaluated in less than half of studies. Only 10 (28%) studies assessed functional improvement using a valid and reliable tool. The present review highlights the paucity of data and the heterogeneity in SPS treatment responses and underscores the need for individualised therapeutic strategies.
Conclusions
Standardised assessment methods in clinical practice are necessary to benefit understanding and approval of future therapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de Neurophysiologie, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France.
- French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, MeLiS-UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France.
- French Reference Centre for Neuromuscular Disorders, Filnemus, ERN Neuro-NMD, CHU La Timone, Aix Marseille University, Marseille, France.
ORCID-Profile: Timothée Lenglet, Shahram Attarian
Förderung
- LFB
Zitieren
APA
Lenglet, T., Honnorat, J., & Attarian, S. (2025). Systematic Review of Immune and Symptomatic Treatments for Stiff‐Person Syndrome. European Journal of Neurology, 32(11). https://doi.org/10.1111/ene.70435
Vancouver
Lenglet T, Honnorat J, Attarian S. Systematic Review of Immune and Symptomatic Treatments for Stiff‐Person Syndrome. European Journal of Neurology. 2025;32(11). doi:10.1111/ene.70435
BibTeX
@article{Lenglet2025,
author = {Lenglet, Timothée and Honnorat, Jérôme and Attarian, Shahram},
title = {Systematic Review of Immune and Symptomatic Treatments for Stiff‐Person Syndrome},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {11},
doi = {10.1111/ene.70435}
}
EUVIMED